Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation sequencing (NGS) for precise patient stratification and treatment selection in metastatic ...
Feb 5, 2025
0
9
The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening all men for the disease, according to a new study by UC San Francisco.
Feb 3, 2025
0
1
Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, according to a new study led ...
Jan 31, 2025
0
16
Genetically predicted rheumatoid arthritis (RA) is causally associated with prostate cancer (PCa), according to a study published online Jan. 10 in Medicine.
Jan 29, 2025
0
0
University of Kentucky Markey Cancer Center researchers have discovered a promising new way to combat therapy-resistant cancers by targeting a specific protein modification, according to a study published in the International ...
Jan 29, 2025
0
43
Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies. However, in addition to being uncomfortable, some of these procedures result in overdiagnosis of low-grade cancers.
Jan 29, 2025
0
6
A study of men with a family history of prostate cancer has discovered an inherited form of prostate cancer. The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases the risk ...
Jan 28, 2025
0
2
The Morecambe Bay area has the highest rate of common cancers compared with the average rates for the whole North West or even England, according to research published in the journal Public Health in Practice.
Jan 28, 2025
0
0
A person's lifetime risk for cancer may begin before they are even born, reports a paradigm-shifting study by Van Andel Institute scientists.
Jan 27, 2025
0
29
For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk classification or treatment decisions, according to a review published in the Annals of Internal ...
Jan 21, 2025
0
0
